SCHEMBL20074121

SCHEMBL20074121

CC(C)c1c(-c2cnn(C3CCCCO3)c2)[nH]c2ncnn2c1=O

nearest known ligand 0.58

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM5B Q9UGL1 7/20 0.58
FLT3 P36888 2/20 0.39
SYK P43405 1/20 0.39
AURKB Q96GD4 1/20 0.39
KDM5A P29375 3/20 0.38
FGFR1 P11362 3/20 0.38
CYP4F2 P78329 1/20 0.34
CYP4A11 Q02928 1/20 0.34
FGFR2 P21802 1/20 0.34
FGFR4 P22455 1/20 0.34
FGFR3 P22607 1/20 0.34
KDR P35968 1/20 0.34
TLR9 Q9NR96 3/20 0.33
TLR8 Q9NR97 3/20 0.33
TLR7 Q9NYK1 3/20 0.33
MCL1 Q07820 1/20 0.33
DDR2 Q16832 1/20 0.32
TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21721764 0.86 KDM5B (0.54) KDM5BKDM5AFGFR1FGFR2FGFR4
SCHEMBL21721727 0.85 KDM5B (0.52) KDM5BKDM5ATLR9TLR8TLR7
SCHEMBL21721735 0.79 KDM5B (0.47) KDM5BKDM5ATLR9TLR8TLR7
SCHEMBL20074327 0.77 KDM5B (0.55) KDM5BFLT3SYKAURKBTLR9
SCHEMBL21681711 0.76 KDM5B (0.48) KDM5BKDM5ATLR9TLR8TLR7
SCHEMBL21720927 0.75 KDM5B (0.51) KDM5BKDM5ATSHR
SCHEMBL20074099 0.74 KDM5B (0.50) KDM5BKDM5ATSHR
SCHEMBL20074329 0.74 KDM5B (0.52) KDM5BSYKKDM5ATSHR
SCHEMBL20074231 0.74 KDM5B (0.58) KDM5BSYKFGFR1FGFR3TLR9
SCHEMBL21721867 0.73 KDM5B (0.53) KDM5BSYKKDM5ATLR9TLR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3525785-B1 KDM5 INHIBITORS MERCK SHARP & DOHME LLC (US) 2025-08-27 EP claimed
US-10975084-B2 KDM5 inhibitors MERCK SHARP & DOHME CORP. (US) 2021-04-13 US disclosed
US-20200048258-A1 KDM5 INHIBITORS MERCK SHARP & DOHME CORP. (US) 2020-02-13 US disclosed
WO-2018071283-A1 KDM5 INHIBITORS MERCK SHARP & DOHME CORP. (US) 2018-04-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200048258-A1 KDM5 INHIBITORS KDM5A, KDM5B, KDM5C KDM5B 2/4885FLT3 922/4885SYK 2161/4885
US-10975084-B2 KDM5 inhibitors KDM5A, KDM5B, KDM5C KDM5B 2/4885FLT3 922/4885SYK 2161/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.